Clinical Trial Update: Autologous Antigen-activated Dendritic Cells in the Treatment of Patients With Colorectal Cancer [EARLY_Phase 1]

View source ↗

Summary

Early-phase study update evaluating autologous antigen-activated dendritic cells for colorectal cancer. No results are provided in this document.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Colorectal Cancer

Drugs mentioned

• Autologous Antigen-activated Dendritic Cells

Snippet

Sponsor: Research Institute of Fundamental and Clinical Immunology | Conditions: Colorectal Cancer | EARLY_Phase 1 | Status: UNKNOWN